Allswell, a specialized behavioral health organization dedicated to serving the LGBTQ+ community, announced on Wednesday the successful closing of a $7 million seed funding round aimed at scaling its virtual care infrastructure and clinical training initiatives. Led by Rethink Impact, the financing round saw significant participation from Magnify Ventures, Ulu Ventures, and Hopelab Ventures, alongside […]
Oxford-based biotechnology firm OMass Therapeutics has announced the successful closure of a $310 million Series C financing round, marking a significant milestone in the company’s efforts to modernize the treatment landscape for rare endocrine and immunological disorders. The capital infusion is primarily earmarked for the clinical advancement of OMS1620, the company’s lead drug candidate currently […]
The healthcare landscape in 2026 stands at a critical juncture where the dual pressures of clinical excellence and fiscal solvency have converged, forcing hospital leadership to re-evaluate the strategic role of the pharmacy department. In a featured MedCity News webinar scheduled for Pharmacy Week 2026, industry experts will convene to address a pivotal shift in […]
The medical technology (MedTech) industry is currently navigating an era defined by unprecedented regulatory complexity, tightening profit margins, and a paradigm shift toward highly specialized, software-integrated medical devices. As manufacturers face mounting pressure to generate recurring revenue through service contracts, consumables, and digital health offerings, the traditional methods of managing product data are proving insufficient. […]
For decades, the American healthcare landscape has relied on a complex and increasingly fragile system of financial cross-subsidization to maintain operational stability. In this long-standing economic model, high-margin activities and specific payer classes have functioned as a financial life raft for essential but money-losing services. Commercially insured surgical patients have effectively subsidized the care of […]
City Therapeutics, a clinical-stage biotechnology firm specializing in the development of small interfering RNA (siRNA) therapies, successfully priced its upsized initial public offering (IPO) late Thursday, raising $200 million to accelerate its efforts in expanding the reach of RNA interference (RNAi) medicines. The Cambridge, Massachusetts-based company offered 11.1 million shares of common stock at $18.00 […]
In a move designed to address the persistent issue of medication non-adherence driven by high costs, the healthcare software giant Epic has announced the upcoming launch of "Prescription Marketplace." This new digital tool is engineered to provide clinicians and health systems with a comprehensive view of medication pricing, including both insurance-backed co-pays and direct cash […]
Iambic Therapeutics, a biotechnology firm at the forefront of integrating artificial intelligence into the structural core of drug discovery, successfully raised $150 million through its initial public offering (IPO) this week. The San Diego-based company, which has gained significant industry attention for its "molecular superintelligence" platform, priced 9.375 million shares of common stock at $16.00 […]
The landscape of senior care and disability support in California is undergoing a significant transformation as Rosarium Health, a specialized platform facilitating home accessibility, announced a strategic partnership with Anthem Blue Cross (Anthem Medi-Cal). This collaboration is designed to streamline and provide critical home modifications for Medi-Cal members, aiming to reduce the incidence of falls […]
The United States healthcare system is rapidly approaching a critical inflection point where traditional delivery models are no longer sufficient to meet the demands of a growing and aging population. According to recent projections, the nation is set to face a physician shortage of up to 86,000 doctors by the year 2036. Within this figure, […]
